Facial Treatment
Microneedling
Facial Treatment
What is microneedling?

Conditions
What conditions are treated with microneedling?
- Fine lines and wrinkles
- Uneven skin texture
- Acne Scars
- Pigmentation spots
- Stretch marks
- Fine lines and wrinkles
- Uneven skin texture
- Acne Scars
- Pigmentation spots
- Stretch marks
The Rejuvena Approach
How does a consultation for microneedling work?
Review of your medical records
Photography
Discussion of your concerns
The microneedling procedure:
Step 1:
Step 2:
Step 3:
A personalized approach
Why choose Clinique Rejuvena?
Microneedling
FAQ
Final treatment results are normally observable between 4-6 weeks after a microneedling session. However, the timeline can vary depending on the targeted problem and the suggested treatment plan.
The number of microneedling sessions needed to achieve best results depends on the problem to be corrected. An initial course of 3-4 treatments spaced 4-6 weeks apart is often recommended. For deeper skin problems such as acne scars, it may be recommended to receive 6 to 8 sessions. For all patients, it is suggested to do periodic maintenance treatments to maintain the results.
Microneedling treatments are very well-tolerated and safe. Post-treatment, you may experience a sunburn-like sensation with a feeling that your skin is dry. Redness and swelling at the treatment sites are the most common side effects but normally resolve within 24-48 hours of treatment. In some cases, small bruises may occur and last for 5-7 days.
Microneedling is not very painful. We always apply a topical anesthetic cream to the treated area in order to make the procedure more comfortable.
Microneedling is a minimally invasive technique that is safe on all skin types. However, this treatment is not recommended for:
- Patients under 20 years of age
- Patients with an infection in the area to be treated
- Patients with active cancer in the area to be treated
- Patients with allergies to stainless steel and anesthetics
- Patients with eczema, rosacea or with an acne flare-up or psoriasis
- Patients with bleeding disorders
- Pregnant or breastfeeding women
- Patients who take Accutane